For LUSC, as shown in Additional file 1: Fig. S7A, FOLR3 promoter presented a significant lower methylation in the tumor tissues than the normal controls, consistent with the hypomethylation of FOLR3 in LUSC blood. Here, FOLR3 is linked to neoplasm.